Mainz Biomed B.V.
MYNZ · NASDAQ
12/31/2024 | 6/30/2024 | 12/31/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Market Cap | $4 | $8 | $21 | $5,617 |
| - Cash | $6 | $1 | $7 | $11 |
| + Debt | $3 | $8 | $7 | $9 |
| Enterprise Value | $1 | $15 | $21 | $5,614 |
| Revenue | $0 | $1 | $0 | $1 |
| % Growth | -28.3% | 142.5% | -57.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 68.6% | 61.3% | 18.7% | 55.6% |
| EBITDA | -$10 | -$9 | -$13 | -$12 |
| % Margin | -2,702.8% | -1,818.7% | -5,872% | -2,479.1% |
| Net Income | -$11 | -$11 | -$5 | -$13 |
| % Margin | -2,847.4% | -2,116.8% | -2,413.5% | -2,652.6% |
| EPS Diluted | -7.71 | -19.73 | -11.73 | -0.9 |
| % Growth | 60.9% | -68.2% | -1,203.3% | – |
| Operating Cash Flow | -$9 | -$8 | -$5 | -$5 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$9 | -$8 | -$5 | -$5 |